NUCLEAR-LOCALIZATION OF THE EPSTEIN-BARR VIRUS/C3D RECEPTOR (CR-2) IN THE HUMAN BURKITT B-LYMPHOMA CELL, RAJI

被引:9
|
作者
GAUFFRE, A
VIRON, A
BAREL, M
HERMANN, J
PUVION, E
FRADE, R
机构
[1] HOP ST ANTOINE, INSERM, U354, UNITE IMMUNOCHIM REGULAT CELLULAIRES & INTERACT VI, F-75571 PARIS 12, FRANCE
[2] CNRS, UPR 272, INST RECH SCI CANC, F-94801 VILLEJUIF, FRANCE
基金
澳大利亚研究理事会;
关键词
D O I
10.1016/0161-5890(92)90044-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epstein-Barr virus/C3d receptor (CR2) is a glycoprotein of mol. wt 140,000 expressed on the surface of Raji cells. We previously isolated phosphorylated CR2 from purified Raji cell nuclei. We have analyzed the nuclear localization of CR2 by electron microscope immunochemistry of thin sections of Raji cells and we have compared the binding properties of CR2 expressed on purified plasma membranes or nuclei. Anti-CR2 mAb immunogold labeling of thin sections of Raji cells identified CR2 at the nuclear surface and also within the nucleus. Nuclear envelope associated CR2 was localized mainly at nuclear pores. Within the nucleus, CR2 was associated with ribonucleoprotein (RNP) interchromatin fibrils. This labeling was preserved in nuclear matrix preparations. CR2 expressed on the surfaces of purified nuclei or on the cell surface interacted with soluble and particle-bound C3bi/C3d. Monoclonal anti-CR2 antibodies, which recognized extracellular domains of CR2, reacted differently with CR2 depending on its subcellular localization. The presence of CR2 in nuclei may be due to translocation of the cell surface CR2 and/or the presence of two distinct intracellular pathways for mature CR2.
引用
收藏
页码:1113 / 1120
页数:8
相关论文
共 50 条
  • [31] ACTIVATION OF LYMPHOCYTES-B BY EPSTEIN-BARR-VIRUS CR-2 RECEPTOR INTERACTION
    MASUCCI, MG
    SZIGETI, R
    ERNBERG, I
    HU, CP
    TORSTEINSDOTTIR, S
    FRADE, R
    KLEIN, E
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (06) : 815 - 820
  • [32] EXPRESSION OF FUNCTIONAL HUMAN EPSTEIN-BARR-VIRUS C3D RECEPTOR ([CR-2] CD21) ON INSULINOMA CELL-LINE - INDUCTION OF TUMOR REJECTION BUT NOT DIABETES IN SYNGENEIC RATS
    CAREL, JC
    HOLERS, VM
    CHICK, WL
    LITTMAN, D
    LACY, PE
    DIABETES, 1991, 40 (07) : 809 - 814
  • [33] The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding
    Prota, AE
    Sage, DR
    Stehle, T
    Fingeroth, JD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (16) : 10641 - 10646
  • [34] EPSTEIN-BARR VIRUS (EBV) INFECTION OF MURINE L-CELLS EXPRESSING RECOMBINANT HUMAN EBV/C3D RECEPTOR
    AHEARN, JM
    HAYWARD, SD
    HICKEY, JC
    FEARON, DT
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (23) : 9307 - 9311
  • [35] HYDRODYNAMIC, ELECTRON-MICROSCOPIC, AND LIGAND-BINDING ANALYSIS OF THE EPSTEIN-BARR VIRUS C3DG RECEPTOR (CR-2)
    MOORE, MD
    DISCIPIO, RG
    COOPER, NR
    NEMEROW, GR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1989, 264 (34) : 20576 - 20582
  • [36] HUMAN-COMPLEMENT RECEPTORS FOR C3B (CR-1) AND C3D (CR-2)
    FEARON, DT
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1985, 85 (01) : S53 - S57
  • [37] EPSTEIN-BARR VIRUS BINDING TO VIRUS-CARRYING CELL-LINES IS ENHANCED IN THE PRESENCE OF C-3 AND C3D
    WELLS, A
    KOIDE, N
    EGGERTSEN, G
    LUNDWALL, A
    GODAL, T
    STEEN, HB
    KLEIN, G
    JOURNAL OF GENERAL VIROLOGY, 1984, 65 (MAR): : 507 - 513
  • [38] STRUCTURAL REQUIREMENTS FOR C3D,G EPSTEIN-BARR-VIRUS RECEPTOR (CR-2 CD21) LIGAND-BINDING, INTERNALIZATION, AND VIRAL-INFECTION
    CAREL, JC
    MYONES, BL
    FRAZIER, B
    HOLERS, VM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1990, 265 (21) : 12293 - 12299
  • [39] ESTABLISHMENT OF 2 EPSTEIN-BARR VIRUS NEGATIVE BURKITT CELL-LINES FROM A PATIENT WITH AIDS AND B-CELL LYMPHOMA
    GANSER, A
    CARLOSTELLA, C
    BARTRAM, CR
    BOEHM, T
    HEIL, G
    HENGLEIN, B
    MULLER, H
    RAGHAVACHAR, A
    VONBRIESEN, H
    GRIESINGER, F
    VOLKERS, B
    RUEBSAMENWAIGMANN, H
    HELM, EB
    HOELZER, D
    BLOOD, 1988, 72 (04) : 1255 - 1260
  • [40] EPSTEIN-BARR-VIRUS COMPLEMENT C3D RECEPTOR IS AN INTERFERON-ALPHA RECEPTOR
    DELCAYRE, AX
    SALAS, F
    MATHUR, S
    KOVATS, K
    LOTZ, M
    LERNHARDT, W
    EMBO JOURNAL, 1991, 10 (04): : 919 - 926